Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Business Profile with Financial and SWOT Analysis

April 2024 | 30 pages | ID: AD1553EC478B1EN
datamining

Abstracts

Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Business Profile with Financial and SWOT Analysis provides access to trustworthy data on the company and its performance, presenting an all-around view. It offers an insightful overview of the company’s structure and recent operations, includes SWOT analysis, highlights product and service offerings, covers the latest important corporate actions and financial results.
 
 Scope

• Business Description – A detailed description of the company’s principal activities.
• Locations, Subsidiaries, Associated Companies – A list of key locations, subsidiaries and associated companies of Amsterdam Molecular Therapeutics (AMT) Holding N.V. with contact details.
• Milestones and History – An overview of the major events associated with the company.
• Key Employee Information – A list of Amsterdam Molecular Therapeutics (AMT) Holding N.V. key executives and their brief biographies.
• Major Products and Services – A list of major products, services and brands of the company.
• SWOT Analysis – An in-depth analysis of the company’s Strengths, Weakness, Opportunities and Threats.
• Financial Analysis - Updated info on income statement, balance sheet and cash flows key figures; main financial ratios and capital market snapshot.
• Key Competitors – A list of key Amsterdam Molecular Therapeutics (AMT) Holding N.V. competitors.
• Latest News – Company related news bulletins.

Contents

1 AMSTERDAM MOLECULAR THERAPEUTICS (AMT) HOLDING N.V. - OVERVIEW

1.1 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Business Description
1.2 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Locations, Subsidiaries, Associated Companies
1.3 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Milestones and History

2 AMSTERDAM MOLECULAR THERAPEUTICS (AMT) HOLDING N.V. - KEY EMPLOYEE INFORMATION

3 AMSTERDAM MOLECULAR THERAPEUTICS (AMT) HOLDING N.V. - OWNERSHIP AND MAJOR HOLDERS

4 AMSTERDAM MOLECULAR THERAPEUTICS (AMT) HOLDING N.V. - MAJOR PRODUCTS AND SERVICES

5 AMSTERDAM MOLECULAR THERAPEUTICS (AMT) HOLDING N.V. - SWOT ANALYSIS

5.1 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Strengths
5.2 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Weaknesses
5.3 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Opportunities
5.4 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Threats

6 AMSTERDAM MOLECULAR THERAPEUTICS (AMT) HOLDING N.V. – FINANCIAL ANALYSIS

6.1 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Financial Statements
6.1.1 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Income Statement
6.1.2 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Balance Sheet
6.1.3 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Cash Flow Statement
6.2 Amsterdam Molecular Therapeutics (AMT) Holding N.V. - Financial Snapshot
6.3 Amsterdam Molecular Therapeutics (AMT) Holding N.V. – Stock Market Snapshot

7 AMSTERDAM MOLECULAR THERAPEUTICS (AMT) HOLDING N.V. - KEY COMPETITORS

8 AMSTERDAM MOLECULAR THERAPEUTICS (AMT) HOLDING N.V. - LATEST NEWS 

APPENDIX

About datamining
Sources and Methodology
Ratio Definitions
Disclaimer

*Please note that this report is a half ready publication.

It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 2-3 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. 

List Of Tables

LIST OF TABLES

Table 1: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Key Facts
Table 2: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Offices and Representations
Table 3: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Milestones and History
Table 4: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Key Executives
Table 5: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Major Shareholders
Table 6: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Products and Services
Table 7: Amsterdam Molecular Therapeutics (AMT) Holding N.V. SWOT Analysis
Table 8: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Profitability
Table 9: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Management Effectiveness
Table 10: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Income Statement
Table 11: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Balance Sheet
Table 12: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Cash Flow Statement
Table 13: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Income Statement Key Figures
Table 14: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Balance Sheet Key Figures
Table 15: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Cash Flow Key Figures
Table 16: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Capital Market Snapshot

List Of Figures

LIST OF FIGURES

Figure 1: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Operating Margin Chart
Figure 2: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Profit Margin Chart
Figure 3: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Return on Assets (ROA) Chart
Figure 4: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Return on Equity (ROE) Chart
Figure 5: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Debt to Equity Chart
Figure 6: Amsterdam Molecular Therapeutics (AMT) Holding N.V. Current Ratio Chart
Figure 7: Amsterdam Molecular Therapeutics (AMT) Holding N.V. 1-year Stock Chart
Figure 8: Amsterdam Molecular Therapeutics (AMT) Holding N.V. 5-year Stock Chart